Скачать
A Phase II trial evaluating CD19/CD22 bispecific CAR T-cell therapy in R/R DLBCL
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2026-01-12
Просмотров: 17
Описание:
In this video, Liang Wang, PhD, Beijing Tongren Hospital, Beijing, China, discusses the results of a Phase II trial (NCT06081478) investigating CD19/CD22 bispecific CAR T-cell therapy for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). The study demonstrated impressive efficacy and a favourable safety profile in this patient population. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
